Burkehill Global Management’s MapLight Therapeutics MPLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-75,000
Closed -$2.69M – 184
2026
Q2
$2.69M Hold
75,000
– – 0.1% 121
2026
Q1
$1.52M Hold
75,000
– – 0.08% 142
2025
Q4
$1.32M Buy
+75,000
New +$1.26M 0.09% 138

Other funds holding MPLT

Burkehill Global Management's MPLT Position: Q3 2026 in Review

Burkehill Global Management sold out of MapLight Therapeutics (MPLT) in Q3 2026, closing a stake of 75,000 shares — an estimated $2.69M sold.

Burkehill Global Management first reported a position in MPLT in Q4 2025 and held it in 3 quarters. The position peaked at $2.69M in Q2 2026. 98 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

  • Burkehill Global Management reported no remaining MapLight Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Burkehill Global Management sold 75,000 MapLight Therapeutics shares in Q3 2026, an estimated $2.69M.
  • Burkehill Global Management first reported a position in MapLight Therapeutics in Q4 2025 and held it in 3 quarters.
  • Burkehill Global Management's MapLight Therapeutics position peaked at $2.69M in Q2 2026.
  • 98 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on Burkehill Global Management's 13F filing for Q3 2026, filed 16 Nov 2026.